CLAIM CARD
Mechanistically, curcumin's pleiotropic bioactivity is supported by both preclinical and clinical data across multiple pathways. In metabolic contexts, curcumin's effects on lipid profiles and adiposity are consistent with mechanistic human studies demonstrating improved insulin sensitivity and reduced oxidative stress markers (Fang 2025, Gonzalez-Gomez 2025). Antimicrobial applications demonstrate curcumin-loaded nanoparticles targeting bacterial quorum sensing and biofilms, representing a distinct mechanistic axis beyond classical anti-inflammatory pathways (Zubair 2026).
Evidence grade: exploratory
Contradiction status: none
Publication: 2ed54f5a-fbc9-45ec-8fa9-5be79af12b17
Provenance: Derivation Web chain
Citation Support
source_1Flensted-Jensen 2025source_2Flensted-Jensen 2025bsource_3Xu 2025source_4El-Rakabawy 2025source_5Schonenberger 2025